Revolade Liver Toxicity Risk
Revolade Can Cause Liver Toxicity. Our firm is investigating potential lawsuits on behalf of individuals who suffered liver damage after taking Revolade (eltrombopag), a medication manufactured by Novartis that is used to increase platelet counts. It is used to treat patients who have chronic immune thrombocytopenia purpura … [Read more...] about Revolade Liver Toxicity Risk
Revolade Severe Liver Damage Risk
Safety Alert for Revolade. Revolade (eltrombopag) can cause severe, potentially fatal liver injury, Health Canada warns. In a safety alert issued on Aug. 25, the regulators said that some patients experienced cases of severe drug-induced liver injury while taking the drug during clinical trials and post-marketing. Revolade is … [Read more...] about Revolade Severe Liver Damage Risk
Revolade, Known in the U.S. as Promacta, Tied to Severe Hepatotoxicity Risks
The use of Revolade (eltrombopag) may cause severe hepatotoxicity and potentially deadly fatal liver injury, warns Canada’s health regulator, Health Canada, according to Healthy Canadians, Government of Canada. Revolade, which is a thrombopoietin receptor agonist, is manufactured and marketed by GlaxoSmithKline under the trade name … [Read more...] about Revolade, Known in the U.S. as Promacta, Tied to Severe Hepatotoxicity Risks
